F2G logo

F2G Alternatives & Competitors

12 companies similar to F2G — The rare fungal disease company

Ansun Biopharma, Inc. logo — alternative to F2G

Ansun Biopharma, Inc.

Discovering solutions for the world

Actio Biosciences, Inc. logo — alternative to F2G

Actio Biosciences, Inc.

From One To Many.

Prevail Therapeutics logo — alternative to F2G

Prevail Therapeutics

Wholly owned subsidiary of Eli Lilly and Company

Solid Biosciences logo — alternative to F2G

Solid Biosciences

#TogetherWeAreSolid

Track all F2G competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works
BridgeBio logo — alternative to F2G

BridgeBio

We move at the speed of patient need.

GENOME INSIGHT INC. logo — alternative to F2G

GENOME INSIGHT INC.

Cancer whole genome platform company

Biogen logo — alternative to F2G

Biogen

Innovative therapies worldwide for people living with serious neurological and neurodegene...

Ultragenyx logo — alternative to F2G

Ultragenyx

Going Beyond Every Day

Avidity Biosciences, Inc. logo — alternative to F2G

Avidity Biosciences, Inc.

At Avidity, we are developing a new class of oligonucleotide-based therapies.

bluebird bio logo — alternative to F2G

bluebird bio

Pursuing curative gene therapies to give patients and their families more bluebird days.

Spero Therapeutics logo — alternative to F2G

Spero Therapeutics

Clinical-stage biotech company focused on rare diseases and diseases with high unmet need

Neurocrine Biosciences logo — alternative to F2G

Neurocrine Biosciences

You Deserve Brave Science

About F2G

The rare fungal disease company

Services

Development of Antifungal Therapies, Research and Development in Fungal Infections, Early Access to Investigational Therapies

Target Customers

Patients with Rare Fungal Infections, Healthcare Providers, Medical Researchers

Taxonomy

Biopharmaceutical, Clinical-stage, Fungal Disease, Orotomides, Antifungal Agents, Invasive Fungal Infections, Dihydroorotate Dehydrogenase, Pyrimidine Biosynthesis, Olorofim, Fungicidal Activity, Rare Mould Infections, Phase 3 Trial, Orphan Drug Status, Breakthrough Therapy Designation, Proprietary Genomics Technology

Business Model

B2B, B2D

Revenue Model

Product Sales, Licensing, Service Fee

Frequently Asked Questions

Top alternatives to F2G include Ansun Biopharma, Inc., Actio Biosciences, Inc., Prevail Therapeutics, Solid Biosciences, BridgeBio. These companies serve similar markets and are frequently compared.
Bounce Watch tracks 12 companies similar to F2G based on industry overlap, target customers, and business model.
The rare fungal disease company

Don't just read about them. Follow them.

BounceWatch watches F2G and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

Compiled from the BounceWatch company index. We last looked at F2G on 11 Mar 2026. The 12 companies listed here were last checked between 28 Jan 2026 and 3 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy